IDO1 and autoimmune hepatitis: In a murine model of autoimmune hepatitis, hepatic IDO1 activation accelerates the Kyn pathway, which via AhR signaling attenuates Th17 differentiation, expands Tregs, and suppresses Akt phosphorylation, ultimately ameliorating liver injury (49).